SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Correction to: AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial.

Lawrence, DS; Youssouf, N; Molloy, SF; Alanio, A; Alufandika, M; Boulware, DR; Boyer-Chammard, T; Chen, T; Dromer, F; Hlupeni, A; et al. Lawrence, DS; Youssouf, N; Molloy, SF; Alanio, A; Alufandika, M; Boulware, DR; Boyer-Chammard, T; Chen, T; Dromer, F; Hlupeni, A; Hope, W; Hosseinipour, MC; Kanyama, C; Lortholary, O; Loyse, A; Meya, DB; Mosepele, M; Muzoora, C; Mwandumba, HC; Ndhlovu, CE; Niessen, L; Schutz, C; Stott, KE; Wang, D; Lalloo, DG; Meintjes, G; Jaffar, S; Harrison, TS; Jarvis, JN (2019) Correction to: AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial. Trials, 20 (1). p. 48. ISSN 1745-6215 https://doi.org/10.1186/s13063-018-3155-9
SGUL Authors: Molloy, Sile

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution.

Download (245kB) | Preview

Abstract

Following publication of the original article [1], we have been notified that one of the author names was listed incorrectly. Both incorrect and correct author names are presented below. The original publication has been corrected.

Item Type: Article
Additional Information: © The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Keywords: 1102 Cardiovascular Medicine And Haematology, 1103 Clinical Sciences, Cardiovascular System & Hematology, General & Internal Medicine
SGUL Research Institute / Research Centre: Academic Structure > Infection and Immunity Research Institute (INII)
Journal or Publication Title: Trials
ISSN: 1745-6215
Language: eng
Dates:
DateEvent
14 January 2019Published
28 December 2018Accepted
Publisher License: Creative Commons: Attribution 4.0
PubMed ID: 30642386
Go to PubMed abstract
URI: http://openaccess.sgul.ac.uk/id/eprint/110557
Publisher's version: https://doi.org/10.1186/s13063-018-3155-9

Actions (login required)

Edit Item Edit Item